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Abstract
Salmonella is an intracellular bacterial pathogen that replicates within a membrane-bound vacuole in host cells. The major
lysosomal membrane proteins 1 and 2 (LAMP-1 and LAMP-2) are recruited to the Salmonella-containing vacuole as well as
Salmonella- associated filaments (Sifs) that emerge from the vacuole. LAMP-1 is a dominant membrane marker for the
vacuole and Sifs. Its colocalization with both is dependent on a major secreted bacterial virulence protein, SifA. Here, we
show that SifA is required for the recruitment of LAMP-2 and can be used as a second independent marker for both the
bacterial vacuolar membrane and Sifs. Further, RNAi studies revealed that in LAMP-1 depleted cells, the bacteria remain
membrane bound as measured by their association with LAMP-2 protein. In contrast, LAMP-2 depletion increased the
amount of LAMP-1 free bacteria. Together, the data suggests that despite its abundance, LAMP-1 is not essential, but LAMP-
2 may be partially important for the Salmonella-containing vacuolar membrane.
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Introduction
Salmonella infection causes millions of infections each year
resulting in hundreds of thousands of deaths [1]. Serovar S.
typhimurium, in particular, causes gastroenteritis in humans and
enteric fever in animal hosts [2]. It is classified as a biodefense
agent because it has the potential, and indeed, has been used to
deliberately contaminate the food and water supply [3]. Salmonella
species also now represents a leading cause of gram-negative
bacterial meningitis in the developing world [1].
Salmonella is a facultative, intracellular, bacterial pathogen that
replicates within a membrane-bound vacuole in both epithelial
cells and in macrophages [4]. Infection initially occurs in the
gastrointestinal tract as a result of ingesting contaminated foods.
Once ingested, the bacteria cross the intestinal epithelial barrier by
invading epithelial and M cells of the Peyer’s patches [5].
Following the initial invasion, Salmonella serovars capable of
causing systemic infection survive and replicates inside macro-
phages of the spleen and liver [5].
Salmonella is able to invade both phagocytic and non-phagocytic
cells. Non-phagocytic cells are invaded by utilization of a Type III
secretion system (TTSS) located on the Salmonella pathogenicity
island -1 (SPI-1) [6]. Once the bacteria enter the cell, whether SPI-
1 TTSS mediated or by phagocytosis, the Salmonella containing
vacuole (SCV) becomes acidified and a second TTSS, located on
Salmonella pathogenitiy island-2 (SPI-2), is activated [7]. The SPI-2
TTSS secreted effectors modify the host cell, preventing fusion of
the SCV with lysosomes and allowing for bacterial replication
within the vacuole [8].
A major SPI-2 effector, SifA, is known to be responsible for the
stability of the SCV and formation of Salmonella-induced filaments
(Sifs) [9]. Sifs are long, membranous extensions that radiate out
from the SCV and are labeled by lysosome-associated membrane
protein-1 (LAMP-1). Late in infection, Sifs are formed along
microtubules once the bacteria start replicating [10]. In addition to
Sif formation, SifA is required for the recruitment of LAMP-1 to
the SCV [8,11], and this is thought to be a major mechanism for
membrane growth and stability at the SCV. Although late
endosomal/lysosomal membrane proteins like the mannose 6-
phosphate receptor are not found at the SCV [12], a second
lysosomal membrane protein, LAMP-2, is also detected at the
SCV [13]. However, it is not known whether analogous to LAMP-
1, LAMP-2 recruitment also requires SifA or a distinct SPI-2
effector.
LAMP-1 and LAMP-2 are both type I transmembrane proteins.
Each has a large lumenal domain which is highly glycosylated, and
a short C-terminal cytoplasmic tail [14]. They share 37% amino
acid sequence identity, but are distinct proteins which most likely
diverged relatively early in evolution [15]. They both function in
lysosome stability by protecting the lysosome membrane from
hydrolytic damage [14,15]. LAMP-2 also functions in chaperone-
mediated autophagy [16] and immunity [17]. LAMP-1 is known
to be more abundant than LAMP-2 [14,15]. Although both
proteins are well characterized in mammalian cells, their
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membrane remains unknown.
Here, we establish that although LAMP-1 is predominantly
used as a membrane marker for the SCV, under normal
conditions of intracellular infection S. typhimurium specifically and
quantitatively associate with LAMP-2. Therefore, LAMP-2 can
serve as a second marker of the SCV. By utilizing these two
LAMPs as independent markers for the SCV and examining
RNAi treated cells, we evaluated the relative contribution of each
to the stability of the SCV membrane. These are the first studies
investigating the requirement of resident lysosomal membrane
proteins at the SCV.
Results
LAMP-2 is recruited to the S. typhimurium containing
vacuole in infected cells
Multiple studies have shown that LAMP-1 is recruited by the
SCV and that LAMP-1 is localized to Sifs [2,8,9]. However, the
relationship between LAMP-2 and the intravacuolar bacteria has
been less well investigated. Several papers have indicated that
LAMP-2 is localized to the SCV, but a comparative, side-by-side
analysis of LAMP-2 and LAMP-1 recruitment to the SCV and Sifs
has not been undertaken. We, therefore, infected HeLa cells with
Salmonella (expressing GFP to ease detection of bacteria) and allowed
the infection to proceed for 18 hours. After this period, the cells
were fixed and immuno-stained to detect LAMP-1 or LAMP-2, and
subsequently imaged. As expected, LAMP-1 was detected sur-
rounding intracellular bacteria (at the SCV, Fig. 1A) and on Sif
membranes (indicated by arrow in Fig. 1A, panelsii and iii).LAMP-
2 was also associated with intracellular bacteria and with Sifs
(Fig. 1A, iv–vi). On average, 80–100% of intracellular bacteria were
labeled by both LAMP-1 and LAMP-2 (Fig. 1B) suggesting that
both proteins are prominently associated with the SCV and Sifs.
This suggested that like LAMP-1, LAMP-2 may also be used as a
major marker of SCVs and Sifs.
LAMP-2 recruitment to the SCV is reduced in the absence
of SifA
As indicated earlier, previous studies have demonstrated that
the Salmonella SPI-2 effector protein, SifA, is required for LAMP-1
recruitment to the SCV [18]. Since LAMP-1 and LAMP-2 are
related proteins, we were interested in determining whether SifA is
required for LAMP-2 recruitment to the SCV. To do this, we
wanted to examine DsifA mutants, but prior work has shown that
these mutants escape from the vacuole after the SPI-2 TTSS is
activated [19]. However, it has also been shown that if sifA is
knocked-out in conjunction with its antagonist, the SPI-2 effector
sseJ, the bacteria remain in the SCV [20]. In light of this, LAMP-2
recruitment was compared between the double mutant, DsseJ/
DsifA, relative to the DsseJ mutant.
To determine if SifA was required for the recruitment of
LAMP-2, HeLa cells were infected with DsseJ/DsifA or DsseJ
bacteria, fixed and immuno-stained to detect LAMP-2, and
subsequently imaged (Materials and Methods). As shown, DsseJ
mutants recruited a high level of LAMP-2 to the SCV (Fig. 2A i–
iii), which was comparable to that seen with wild type bacteria
(Fig. 1). In contrast, the DsseJ/DsifA-Salmonella showed significantly
lower levels of LAMP-2 at the SCV (Fig. 2A, iv–vi). Quantitative
analyses revealed a significant decrease (P=0.0001) of 40% in the
amount of LAMP-2 recruited to the SCV of DsseJ/DsifA mutants
relative to DsseJ (Fig. 2b). These results suggest that SifA is
required for a significant fraction of LAMP-2 recruitment to
intracellular bacteria. SifA is also required for the recruitment of
LAMP-1.
LAMP-2 knockdown promotes reduction of LAMP-1 at
the SCV membrane
In order to determine the relative importance of LAMP-1 and
LAMP-2 to Salmonella infection, we used RNAi to knockdown
levels of these proteins in cells. Cytoplasmic actin was used as a
measure of total cellular protein and cell growth. As shown in
Fig. 3A, scrambled RNAi oligos did not significantly alter total
Figure 1. LAMP-2 localizes to the SCV and Sifs. A. HeLa cells were infected with wild type bacteria expressing GFP. 18 hours post-infection, the
monolayers were fixed and immuno-stained to detect LAMP-1 (i–iii) or LAMP-2 (iv–vi). Green bacteria co-localized with LAMP-1 and LAMP-2,
suggesting that both are recruited to the SCV (indicated by the dotted line). Sifs, which are marked by arrows, are also labeled by LAMP-1 and LAMP-
2. B. The extent of LAMP-2 labeling of the SCV is comparable to that seen for LAMP-1. Volocity image analysis software was used to quantitate the
colocalization of GFP-Salmonella and LAMP-1 or LAMP-2. A two-tailed P value was obtained from the Volocity quantitation using the Student’s T test.
The P value is=0.56 which indicates there is no significant difference between the colocalization of Salmonella with LAMP-1 or LAMP-2.
doi:10.1371/journal.pone.0003538.g001
LAMP-2 Salmonella Vacuole
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Unexpectedly these scrambled oligos increased LAMP-1 and
LAMP-2 levels in cells. In contrast, specific oligonucleotides
designed to knock down LAMP-1 and LAMP-2 consistently
showed reduced actin levels. These cells were nonetheless
adherent and viable, suggesting they were slowed in growth.
However, despite reduced growth cells knocked down in LAMP-1
displayed LAMP-2 levels that were modestly increased relative to
control incubations. Similarly cells knocked down in LAMP-2
displayed LAMP-1 levels that were close to those seen in control
incubations. Importantly actin levels in cells knocked down in
LAMP-1 or LAMP-2 were comparable and this enabled us to
ascertain the effect of knockdown of each protein on the
recruitment of the other, to the SCV. To facilitate the analysis
we determined levels of LAMP-1 and LAMP-2 detected
normalized for actin (Fig. 3B–C) for all samples. In summary
the data in Fig. 3A–C suggested that, knockdown of LAMP-2 did
not abrogate LAMP-1 levels in cells and conversely knock down of
LAMP-1 did not abrogate LAMP-2 levels in cells. Since we
showed in Fig. 1 that both LAMP-1 and LAMP-2 could be used to
mark the SCV, the data in Fig. 3A–C suggested that we could
investigate the consequence of depleting each LAMP to the
stability of the SCV by using the other to mark the SCV.
Thus, cells knocked down in LAMP-1 or LAMP-2, along with
controls, were infected with S. typhimurium, then fixed and immuno-
stained (Fig. 3D). In untreated cells or cells treated with control
RNAi oligonucleotides, bacteria were quantitiatively associated
with both LAMP-1 and LAMP-2 (Fig. 3D panels i–iii and Fig. 3E).
Furthermore when LAMP-1 was knocked down, bacteria
continued to quantitatively associate with LAMP-2. However,
when LAMP-2 was knocked down, approximately 40% of bacteria
were no longer positive for LAMP-1 (Fig. 3D, panels vii–inset, viii
and Fig. 3E). These LAMP-1-negative bacteria were detected in
large clusters containing 20+ bacteria.(Fig. 4). The other 60%
remained associated with LAMP-1 (Fig. 3D, arrowheads, panel vi–
vii, Fig. 3E) in clusters of five or less bacteria (Fig. 4). These data
suggest that bacteria in large clusters reside in a different vacuolar
compartment or may be free in the cytoplasm. Regardless, they
proliferate at an accelerated rate suggesting that their intracellular
environment is functionally altered. Together, the data in Figures 3
and 4 suggest that although LAMP-1 is a major membrane marker
for the SCV, its loss in cells does not affect the stability of the SCV.
In contrast, LAMP-2 depletion measurably reduced detection of
the SCV marker LAMP-1, suggesting LAMP-2 contributes to
either the composition and function, or the stability of the SCV
membrane.
Discussion
The SCV is a lysosmal-like compartment in that it recruits
major lysosomal membrane proteins, LAMP-1 and LAMP-2
[8,11–13]. However, it excludes digestive, soluble enzymes, such
as cathepsins, which are usually found in the lumen of the
lysosome. The SCV also excludes membrane-bound receptors,
such as the mannose-6-phosphate receptor that deliver cathepsins
and other soluble cargo to the lysosomes [12]. Characterization of
the recruitment of LAMP-2 along with that of LAMP-1 enabled
each to be used as a marker for the SCV, as well as testing (in
RNAi experiments) whether each was important to the SCV
membrane.
Numerous effectors secreted by S. typhimurium modify the host
cell and the functions of each effector appear to be distinct.
Examples include SseG, which is thought to be important for
recruitment of the Golgi; SseJ, which esterifies host cholesterol;
SipB, which binds and activates caspase-1, SopE1 and SopE2 act
as G-nucleotide exchange factors; and SipA and SipC, which
directly bind actin and modulating bacterial uptake [21–25].
SifA influences the position of the SCV, is necessary for Sif
production, and is required for the recruitment of LAMP-1 to
these membranes [9,26]. Our data suggest that SifA is also
Figure 2. LAMP-2 recruitment is mediated by SifA. A. HeLa cells were infected with DsseJ (i–iii) or DsseJ/DsifA (iv–vi) mutants (green). 18 hours
post-infection, the monolayers were fixed and imunno-stained for LAMP-2 (red). DsseJ bacteria colocalize with LAMP-2 (i–iii). DsseJ/DsifA mutants
(green; iv–vi), show significantly reduced co-localization with LAMP-2. B. Volocity image analysis software was used to quantitate association of
bacteria with LAMP-2 in DsseJ/DsifA and DsseJ mutants. A two-tailed P value was obtained from the Volocity quantitation using the Student’s T test.
The P value is 0.0001 which indicates there is significant difference between the colocalization of LAMP-2 with DsseJ versus DsseJ/DsifA.
doi:10.1371/journal.pone.0003538.g002
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SifA is essential for membrane stability of the SCV. In addition,
our data implicate the presence of a cellular mechanism engaged
by SifA that enables the recruitment of LAMP-1 and LAMP-2,
while circumventing mannose-6-phosphate receptor trafficking
between the Golgi and lysosomes. Further, although LAMP-1 is
Figure 3. LAMP-2 knockdown increases prevalence of LAMP-1 depleted bacteria. A. RNAi treated HeLa cells were lysed 48 hours after
RNAi treatment was initiated. Equal volumes of whole cell lysates were analyzed by Western for LAMP-1, LAMP-2 and actin (used as a loading control).
B. LAMP-1:actin ratio relative to that in scrambled RNAi samples (set to 100) C. LAMP-2:actin ratio relative to that in scrambled RNAi samples (set to
100). The data in A–C show that LAMP-1 RNAi specifically knocks down LAMP-1 but not LAMP-2. In addition, LAMP-2 RNAi specifically knocks down
LAMP-2 and not LAMP-1 D. HeLa cells were transfected with RNAi oligos to knockdown either LAMP-1 (i–iv) or LAMP-2 (v–ix). 48 hours after RNAi
treatment, the cells were infected with Salmonella for 6 hours. The cells were then fixed and immuno-stained. LAMP-1 knockdown cells were
immuno-stained for LAMP-2 and revealed consistent colocalization of Salmonella with LAMP-2 (iv). However, immuno-staining of LAMP-2 knockdown
cells for LAMP-1 revealed reduced association of LAMP-1 in a subset of bacterial clusters (viii). Clusters of bacteria containing normal levels of LAMP-2
are shown by arrow heads. E. Volocity quantitation of bacteria association with LAMP-containing membrane in knockdown cells. A two-tailed P value
was obtained from the Volocity quantitation using the Student’s T test. Asterisk indicates the P value is less than 0.001 which indicates that the
difference is significant.
doi:10.1371/journal.pone.0003538.g003
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protein marker of the SCV, we find that it is not essential for the
SCV membrane. In contrast, LAMP-2 which is present at three
fold lower levels, does contribute in a measurable way to the
composition and/or maintenance of a stable SCV.
In mouse models, LAMP-1/LAMP-2 double knockout is
embryonically lethal [27]. However, the single knockouts of
LAMP-1 or LAMP-2 are both viable [27–29]. The LAMP-1
knockout mice display a mild phenotype, and apart from mild
regional astrogliosis and altered immunoreactivity against cathep-
sin D in the brain, all tissues in the mouse are similar to controls
[28]. In addition, their lysosomes are similar to control mice in
both form and function [28]. In contrast, the LAMP-2 knockout
mice display a more severe phenotype. Fifty percent of the mice
die by 6 weeks [29]. In these mice, the knockout of LAMP-2 leads
to cardiomyopathy and an increase in the amount of autophagy/
lysosome compartments in many tissues [30]. However, these
compartments are less efficient at protein degradation than their
wild-type counterparts [30]. These symptoms mirror those of
human Danon disease which is attributed to mutations in LAMP-2
[30,31]. Thus, despite similarities in location, LAMP-2 function in
the host is likely to be distinct from that of LAMP-1. Our data
support that LAMP-2 provides a more critical function in
formation, composition and/or maintainence of the SCV.
Materials and Methods
Antibodies and reagents
Anti-LAMP-1 mouse monoclonal antibody, H4A3, was pur-
chased from Iowa Developmental Studies Hybridoma Bank and
used at 1:1000. Anti-LAMP-2 mouse monoclonal antibody, H4B4,
was purchased from Iowa Developmental Studies Hybridoma
Bank and used at 1:1000. Anti-actin mouse monoclonal antibody,
MAB1501, was purchased from Millipore Corporation and used
at 1:2500. Rhodamine-conjugated goat IgG fraction raised against
mouse IgG was purchased from ICN/Cappel (Solon, OH).
Cell culture
HeLa cell lines (ATCC) were grown in Modified Eagles
Medium (MEM) (ATCC) supplemented with 10% (v/v) fetal calf
serum. The cell lines were maintained at 37uCi n5 %C O 2,
passaged every 2–3 days, and used for experiments at a passage
number less than 20.
Bacterial strains and growth conditions
The S. typhimurium wild type strain SL1344 (ATCC) was used for
all experiments and construction of mutants, except where
otherwise noted. Expression of GFP in this strain and additional
strains was accomplished by the introduction plasmid pFPV25.1
[32]. The DssaT mutant has been described previously [33,34],
and was a gift from Dr. Bradley Jones (University of Iowa).
Knockouts in sseJ and sifA were constructed using the method
developed by Datsenko et al. [35], a PCR-based knockout strategy
based on the Red system [36]. For infections, bacteria were grown
to late log phase in LB containing 0.3 M NaCl without shaking.
Optical density measurements at 600 nm were taken to calculate
bacterial cell density. An optical density of 1.0 was approximately
equal to 1.3610
9 CFU/ml. Ampicillin (50 mg/ml), kanamycin
(50 mg/ml), and streptomycin (50 mg/ml) were used for selection
of bacterial strains.
Cell infections
HeLa cells were seeded at 3610
5 per well in a 24-well tissue
culture plate, and were allowed to grow for at least 12 hours prior
to infection. Bacterial cultures were washed and diluted into serum
free MEM, added to Hela cells at a multiplicity of infection of 100,
and subjected to centrifugation at 1000 rpm for 5 minutes.
Following centrifugation, the cells were placed at 37uC for 1 hour,
washed three times with serum free medium, and then incubated
in 100 mg/ml of gentamicin in 10% FBS-MEM for 60–
90 minutes. After this time, the concentration of gentamicin was
adjusted to 10 mg/ml for the remainder of the experiment.
Indirect immunofluorescence assays
HeLa cells were grown on glass coverslips, infected with
bacteria, fixed, and then processed for immunofluorescence [37].
Primary antibodies to the following markers from indicated
sources were used at the indicated dilutions LAMP-1 (H4A3,
mouse, Iowa Developmental Studies Hybridoma Bank 1:1000)
and LAMP-2 (H4B4, mouse, Iowa Developmental Studies
Hybridoma Bank 1:1000). The secondary antibody, rhodamine
conjugated goat anti mouse IgG, was used at dilutions of 1:800
(ICN/Cappel, Solon, OH). Samples were examined by Deltavi-
sion deconvolution fluorescence microscopy using standard UV,
FITC and rhodamine, Cy-5, GFP, RFP filter sets.
Deconvolution fluorescence microscopy and quantitative
image analyses
Fluorescence microscopy and digital image collection were
performed using an Olympus IX inverted fluorescence microscope
and a Photometrix cooled CCD camera (CH350/LCCD) driven
by DeltaVision software from Applied Precision Inc. (Seattle, WA).
Images used for Fluorescence quantification were obtained with a
606, NA 1.4 objective. Briefly, 300-nm optical sections were taken
through the depth of the cell, and DeltaVision software (soft-
WoRx) was used to deconvolve these images. For colocalization
quantitation, a stack of TIFFS for each image was generated and
exported to Volocity software (Improvision, Coventry, UK). For
monolayers infected with wild-type or mutant bacteria, values
were obtained for the total cholesterol in 20 cells. The total
amount of colocalization in each cell was quantitated by
measuring and integrating the intensity values over all selected
voxels in the Filipin UV channel. To obtain values for the SCV-
Figure 4. LAMP-1 depleted Salmonella in LAMP-2 knockdown
cells proliferate at an accelerated rate. Bar plot shows the number
of Salmonella per infected cell. HeLa cells were transfected with RNAi
oligos to knockdown LAMP-1 or LAMP-2. 48 hours after RNAi treatment,
the cells were infected with GFP-Salmonella for 6 hours, then fixed and
immuno-stained. The amount of bacteria per infected cell was counted
and the results shown here. The cells that contained more than 20
bacteria were the ones in which the Salmonella were not contained in
LAMP-1 vacuoles.
doi:10.1371/journal.pone.0003538.g004
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focal plane was selected using the freehand selection tool and the
software was then allowed to extend the selection through all z-
sections in both channels.
Knockdown experiments using siRNA
Small interference RNA (siRNA) against LAMP-1 (59-
AGAAAUGCAACACGUUA-39) and LAMP-2 (59-GCU-
GUGCGGUCUUAUGCAU-39) along with RNAi negative
control (59-AAACTTGTCGACGAGAAGCAA-39) were pur-
chased from Invitrogen (Carlsbad, CA). HeLa cells were
transfected with the siRNA targeting LAMP-1, LAMP-2 or
nonspecific control RNA (100 pmol/ml) using Oligofectamine
according to the manufacturer’s instructions. Knockdown of
LAMP-1 and LAMP-2 was confirmed by Western blot analysis.
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